Analysis of patient data indicated that SphK2 expression was significantly correlated with NSCLC TNM stage (p = 0.017), and expression of miR-338-3p was also significantly correlated with NSCLC TNM stage (p = 0.023). Here, SPHK2 is linked to non-small cell lung carcinoma.